OligoNova Hub – Oligonucleotide Chemistry
Recent user publications
The publications in this database are the result of research conducted at the units of SciLifeLab – both in user projects and technology development.
Personnel
Pär Matsson, Platform Scientific Director
Dmitri Ossipov, Head of Unit
Christian Pett
Maksim Kvach
OligoNova Chemistry
Part of the Drug Discovery and Development Platform
OligoNova offers state-of-the-art drug discovery infrastructure and expertise to researchers and supports the translation of fundamental research findings into patient-benefitting therapeutic molecules.
OligoNova Chemistry primarily provides bioinformatic and chemical design, synthesis, purification and analysis of oligonucleotides and their conjugates, but can also provide development of oligonucleotide-based molecular tools for studying processes in living cells

Services
- Organic synthesis of small molecular weight ligands and building blocks
- Bioinformatic selection of sequences of antisense oligonucleotide candidates for their subsequent
cellular screening - Iterative design, solid-phase synthesis (SPS) and analysis of oligonucleotide libraries with the aim of
identification of hit compunds - SPS and post-synthetic conjugation of oligonucleotides to small molecules, peptides, (bio)polymers,
and nanoparticles - Expertise in organic synthesis, medicinal chemistry, drug delivery, design of molecular tools
Applications
- Bioinformatic and chemical design, synthesis, purification and analysis of oligonucleotides and their
conjugates to setup the molecular basis for development of oligonucleotide therapeutics - Chemical design, synthesis and characterization of oligonucleotide-based molecular tools for studying
dynamics of interaction of oligonucleotides with their targets, in vivo biodistribution, and intracellular
transport
Find out more
Mailing/Visiting
OligoNova
c/o AZ BioVentureHub
Pepparedsleden 1,
431 83 Mölndal,
Sweden
Deliveries
OligoNova
c/o AZ BioVentureHub
Pepparedsleden 3,
431 83 Mölndal,
Sweden